Caspofungin vs. Fluconazole to Prevent Invasive Fungal Infections in Children in Chemotherapy

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

Trial Name

A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)

What is the trial about?

To find out if using Caspofungin will be better than current standard antifungal drug, fluconazole, at preventing invasive fungal infections in children receiving chemotherapy treatment for AML.

Who can participate?

Children who are being treated with chemotherapy for Acute Myeloid Leukemia.

What is involved?

The length of time your child will be treated on this study will be determined by the length of his or her chemotherapy treatment. Before your child takes part in this study, he or she will first get cancer treatment for AML that includes the use of chemotherapy.

Contact Nemours Clinical Trials

Trial Name: A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)

COG#: ACCL0933

Contact Information

(800) 354-5690
clinicaltrials@nemours.org